NCT03504644 2026-02-25Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic LeukemiaEastern Cooperative Oncology GroupPhase 1/2 Active not recruiting40 enrolled 18 charts